These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 10699072)

  • 1. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
    Mehta RG; Williamson E; Patel MK; Koeffler HP
    J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.
    Asou H; Verbeek W; Williamson E; Elstner E; Kubota T; Kamada N; Koeffler HP
    Int J Oncol; 1999 Nov; 15(5):1027-31. PubMed ID: 10536188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
    Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.
    Rubin GL; Duong JH; Clyne CD; Speed CJ; Murata Y; Gong C; Simpson ER
    Endocrinology; 2002 Aug; 143(8):2863-71. PubMed ID: 12130549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of aromatase by nuclear receptors.
    Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
    Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC
    Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes.
    Nagase I; Yoshida S; Canas X; Irie Y; Kimura K; Yoshida T; Saito M
    FEBS Lett; 1999 Nov; 461(3):319-22. PubMed ID: 10567719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
    He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
    Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
    James SY; Lin F; Kolluri SK; Dawson MI; Zhang XK
    Cancer Res; 2003 Jul; 63(13):3531-8. PubMed ID: 12839938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY; Cho IJ; Kim SG
    Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium.
    Tsibris JC; Porter KB; Jazayeri A; Tzimas G; Nau H; Huang H; Kuparadze K; Porter GW; O'Brien WF; Spellacy WN
    Cancer Res; 1999 Nov; 59(22):5737-44. PubMed ID: 10582693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats.
    Tanaka T; Kohno H; Yoshitani S; Takashima S; Okumura A; Murakami A; Hosokawa M
    Cancer Res; 2001 Mar; 61(6):2424-8. PubMed ID: 11289109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.
    Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR
    Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Takahashi Y; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Int J Oncol; 2003 Aug; 23(2):325-31. PubMed ID: 12851681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troglitazone, a ligand for peroxisome proliferator-activated receptor gamma, inhibits chemically-induced aberrant crypt foci in rats.
    Kohno H; Yoshitani S; Takashima S; Okumura A; Hosokawa M; Yamaguchi N; Tanaka T
    Jpn J Cancer Res; 2001 Apr; 92(4):396-403. PubMed ID: 11346461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage between retinoid and fatty acid receptors: implications for breast cancer prevention.
    Stoll BA
    Eur J Cancer Prev; 2002 Aug; 11(4):319-25. PubMed ID: 12195157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.